Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology (Q43467553)

23 November 2017

Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology (English)

1 reference

23 November 2017

0 references

0 references

1 reference

2

1 reference

23 November 2017

Ryuichi Harada

1

1 reference

23 November 2017

Shozo Furumoto

3

1 reference

23 November 2017

Tetsuro Tago

4

1 reference

23 November 2017

Masahiro Maruyama

5

1 reference

23 November 2017

Makoto Higuchi

6

1 reference

23 November 2017

Takeo Yoshikawa

7

1 reference

23 November 2017

Hiroyuki Arai

8

1 reference

23 November 2017

Ren Iwata

9

1 reference

23 November 2017

Yukitsuka Kudo

10

1 reference

23 November 2017

Kazuhiko Yanai

11

1 reference

23 November 2017

26 October 2012

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

23 November 2017

1 reference

23 November 2017

40

1 reference

23 November 2017

125-132

1 reference

23 November 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-012-2261-2

23 November 2017

0 references

cites work

The use of PET in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Recent advances in the development of amyloid imaging agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Sequence of Abeta-protein deposition in the human medial temporal lobe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2261-2

Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease

21 January 2018

1 reference

12 December 2020

The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.

1 reference

12 December 2020

Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease

1 reference

12 December 2020

Silver staining of Alzheimer's neurofibrillary changes by means of physical development.

1 reference

12 December 2020

PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis

1 reference

12 December 2020

An in vivo evaluation of cerebral cortical amyloid with [18F]flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients

1 reference

12 December 2020

10.1007/S00259-012-2261-2

Identifiers

DOI

1 reference

23 November 2017

1 reference